116 related articles for article (PubMed ID: 11370552)
1. [Association between elevated serum VEGF and polarographically measured tumor hypoxia in head and neck carcinomas].
Becker A; Stadler P; Krause U; Utzig D; Hänsgen G; Lautenschläger C; Rath FW; Molls M; Dunst J
Strahlenther Onkol; 2001 Apr; 177(4):182-8. PubMed ID: 11370552
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer.
Oehler MK; Caffier H
Anticancer Res; 2000; 20(6D):5109-12. PubMed ID: 11326678
[TBL] [Abstract][Full Text] [Related]
3. Tumor hypoxia and systemic levels of vascular endothelial growth factor (VEGF) in head and neck cancers.
Dunst J; Stadler P; Becker A; Kuhnt T; Lautenschläger C; Molls M; Haensgen G
Strahlenther Onkol; 2001 Sep; 177(9):469-73. PubMed ID: 11591020
[TBL] [Abstract][Full Text] [Related]
4. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
Werther K; Christensen IJ; Brünner N; Nielsen HJ
Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612
[TBL] [Abstract][Full Text] [Related]
5. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
[TBL] [Abstract][Full Text] [Related]
6. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
[TBL] [Abstract][Full Text] [Related]
7. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Leung P; Luk JM
Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
[TBL] [Abstract][Full Text] [Related]
8. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM
Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen?
Lee JK; Hong YJ; Han CJ; Hwang DY; Hong SI
Int J Oncol; 2000 Jul; 17(1):149-52. PubMed ID: 10853032
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
[TBL] [Abstract][Full Text] [Related]
12. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
Tamura M; Ohta Y
Cancer; 2003 Sep; 98(6):1217-22. PubMed ID: 12973845
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
Peng XP; Li JD; Li MD; Ye XM; Yan WC
Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.
Zhao J; Hu J; Cai J; Yang X; Yang Z
Chin Med J (Engl); 2003 May; 116(5):772-6. PubMed ID: 12875699
[TBL] [Abstract][Full Text] [Related]
15. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
Zhao J; Hu J; Cai J
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.
George DJ; Halabi S; Shepard TF; Vogelzang NJ; Hayes DF; Small EJ; Kantoff PW;
Clin Cancer Res; 2001 Jul; 7(7):1932-6. PubMed ID: 11448906
[TBL] [Abstract][Full Text] [Related]
17. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer.
Stadler P; Becker A; Feldmann HJ; Hänsgen G; Dunst J; Würschmidt F; Molls M
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):749-54. PubMed ID: 10386631
[TBL] [Abstract][Full Text] [Related]
18. [No association between p53 overexpression and polarographically measured tumor oxygenation in patients with head and neck carcinomas].
Becker A; Stadler P; Krause U; Kuhnt T; Hänsgen G; Dettmar P; Feldmann HJ; Rath FW; Molls M; Dunst J
Strahlenther Onkol; 2000 Oct; 176(10):475-80. PubMed ID: 11068594
[TBL] [Abstract][Full Text] [Related]
19. Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment.
Jaroszewicz J; Januszkiewicz M; Flisiak R; Rogalska M; Kalinowska A; Wierzbicka I
Cytokine; 2008 Oct; 44(1):14-7. PubMed ID: 18656381
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
